vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and MATERION Corp (MTRN). Click either name above to swap in a different company.
MATERION Corp is the larger business by last-quarter revenue ($489.8M vs $284.0M, roughly 1.7× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 1.3%, a 95.0% gap on every dollar of revenue. On growth, MATERION Corp posted the faster year-over-year revenue change (12.1% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 12.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Materion Corp. is a multinational company specializing in high-performance advanced materials. Among its products are advanced beryllium metals, thin film deposition materials, high-performance alloys and composites, specialty engineered beryllium, engineered metals, technical ceramics, tantalum, niobium, other precious and non-precious metals, inorganic chemicals, and specialty coatings.
ACAD vs MTRN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $489.8M |
| Net Profit | $273.6M | $6.6M |
| Gross Margin | 90.8% | 13.0% |
| Operating Margin | 6.1% | 2.2% |
| Net Margin | 96.3% | 1.3% |
| Revenue YoY | 9.4% | 12.1% |
| Net Profit YoY | 90.3% | 113.5% |
| EPS (diluted) | $1.61 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $489.8M | ||
| Q3 25 | $278.6M | $444.8M | ||
| Q2 25 | $264.6M | $431.7M | ||
| Q1 25 | $244.3M | $420.3M | ||
| Q4 24 | $259.6M | $436.9M | ||
| Q3 24 | $250.4M | $436.7M | ||
| Q2 24 | $242.0M | $425.9M | ||
| Q1 24 | $205.8M | $385.3M |
| Q4 25 | $273.6M | $6.6M | ||
| Q3 25 | $71.8M | $25.4M | ||
| Q2 25 | $26.7M | $25.1M | ||
| Q1 25 | $19.0M | $17.7M | ||
| Q4 24 | $143.7M | $-48.9M | ||
| Q3 24 | $32.8M | $22.3M | ||
| Q2 24 | $33.4M | $19.0M | ||
| Q1 24 | $16.6M | $13.4M |
| Q4 25 | 90.8% | 13.0% | ||
| Q3 25 | 92.2% | 19.4% | ||
| Q2 25 | 92.2% | 19.1% | ||
| Q1 25 | 91.7% | 18.1% | ||
| Q4 24 | 91.6% | 21.3% | ||
| Q3 24 | 92.5% | 18.5% | ||
| Q2 24 | 92.5% | 19.0% | ||
| Q1 24 | 88.8% | 18.5% |
| Q4 25 | 6.1% | 2.2% | ||
| Q3 25 | 12.8% | 7.9% | ||
| Q2 25 | 12.2% | 8.5% | ||
| Q1 25 | 7.9% | 6.5% | ||
| Q4 24 | 59.1% | -8.8% | ||
| Q3 24 | 12.6% | 7.2% | ||
| Q2 24 | 12.6% | 7.5% | ||
| Q1 24 | 7.4% | 5.8% |
| Q4 25 | 96.3% | 1.3% | ||
| Q3 25 | 25.8% | 5.7% | ||
| Q2 25 | 10.1% | 5.8% | ||
| Q1 25 | 7.8% | 4.2% | ||
| Q4 24 | 55.4% | -11.2% | ||
| Q3 24 | 13.1% | 5.1% | ||
| Q2 24 | 13.8% | 4.5% | ||
| Q1 24 | 8.0% | 3.5% |
| Q4 25 | $1.61 | $0.30 | ||
| Q3 25 | $0.42 | $1.22 | ||
| Q2 25 | $0.16 | $1.21 | ||
| Q1 25 | $0.11 | $0.85 | ||
| Q4 24 | $0.86 | $-2.34 | ||
| Q3 24 | $0.20 | $1.07 | ||
| Q2 24 | $0.20 | $0.91 | ||
| Q1 24 | $0.10 | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $13.7M |
| Total DebtLower is stronger | — | $460.6M |
| Stockholders' EquityBook value | $1.2B | $943.3M |
| Total Assets | $1.6B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $13.7M | ||
| Q3 25 | $258.0M | $16.4M | ||
| Q2 25 | $253.6M | $12.6M | ||
| Q1 25 | $217.7M | $15.6M | ||
| Q4 24 | $319.6M | $16.7M | ||
| Q3 24 | $155.1M | $17.9M | ||
| Q2 24 | $177.1M | $17.1M | ||
| Q1 24 | $204.7M | $13.1M |
| Q4 25 | — | $460.6M | ||
| Q3 25 | — | $458.9M | ||
| Q2 25 | — | $427.6M | ||
| Q1 25 | — | $453.0M | ||
| Q4 24 | — | $443.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $477.9M |
| Q4 25 | $1.2B | $943.3M | ||
| Q3 25 | $917.3M | $934.6M | ||
| Q2 25 | $822.4M | $910.6M | ||
| Q1 25 | $765.2M | $887.9M | ||
| Q4 24 | $732.8M | $868.9M | ||
| Q3 24 | $577.2M | $931.9M | ||
| Q2 24 | $516.7M | $907.1M | ||
| Q1 24 | $464.0M | $889.9M |
| Q4 25 | $1.6B | $1.8B | ||
| Q3 25 | $1.3B | $1.8B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.1B | $1.8B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $976.9M | $1.9B | ||
| Q2 24 | $914.1M | $1.8B | ||
| Q1 24 | $855.1M | $1.8B |
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $19.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | 2.97× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $19.5M | ||
| Q3 25 | $74.3M | $18.3M | ||
| Q2 25 | $64.0M | $49.9M | ||
| Q1 25 | $20.3M | $15.5M | ||
| Q4 24 | $40.4M | $76.3M | ||
| Q3 24 | $63.2M | $5.1M | ||
| Q2 24 | $25.0M | $20.3M | ||
| Q1 24 | $29.1M | $-13.8M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | $-24.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-35.1M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | -5.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -9.1% |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 6.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.5% |
| Q4 25 | -0.18× | 2.97× | ||
| Q3 25 | 1.03× | 0.72× | ||
| Q2 25 | 2.40× | 1.99× | ||
| Q1 25 | 1.07× | 0.88× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 0.23× | ||
| Q2 24 | 0.75× | 1.07× | ||
| Q1 24 | 1.76× | -1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
MTRN
| Electronic Materials | $313.9M | 64% |
| Aerospaceand Defense | $48.4M | 10% |
| Industrial Components | $34.3M | 7% |
| Precision Optics | $27.5M | 6% |
| Other End Market | $22.3M | 5% |
| Energy | $18.8M | 4% |
| Automotive Electronics | $18.5M | 4% |
| Semiconductor | $3.6M | 1% |
| Consumer Electronics | $362.0K | 0% |
